Variable orifice flow
AssigneeEdwards Lifesciences Corporation
InventorsHengchu Cao, Ming H. Wu, Ralph Schneider, Maximilien Evans Launey
Life of this patent
Estimating the term…
Loading patent…
AssigneeEdwards Lifesciences Corporation
InventorsHengchu Cao, Ming H. Wu, Ralph Schneider, Maximilien Evans Launey
Estimating the term…
Described herein are shunt devices configured to achieve a targeted reduction in peak systolic pressure by percutaneously shunting from the superior vena cava to the right pulmonary artery. The shunt devices include a check valve with a cracking pressure to preserve a minimal transpulmonary pressure. Also described herein are flow diversion devices placed between pulmonary circulation vessels and venous vessels. The disclosed flow diversion devices are physiologically responsive through an adjustable orifice that can be adjusted after initial implantation through a non-invasive or minimally invasive procedure. Disclosed herein are flow control systems that are configured to reduce recruitment of blood from the splanchnic system. The flow control systems include a variable orifice constrictor (e.g., a covered stent) and a controller that delivers energy to the constrictor to reduce the cross-sectional area of the lumen through the variable orifice constrictor.
A variable orifice flow control system comprising:
A shunt device configured to alleviate pressure overload of a heart organ, the shunt device comprising:
A flow reducing implant having a variable orifice, comprising:
Dependencies are inferred from the claim text.